291 related articles for article (PubMed ID: 25043982)
1. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival.
Reyes-Gibby CC; Anderson KO; Merriman KW; Todd KH; Shete SS; Hanna EY
J Pain; 2014 Oct; 15(10):1015-22. PubMed ID: 25043982
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
4. Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.
Datema FR; Ferrier MB; van der Schroeff MP; Baatenburg de Jong RJ
Head Neck; 2010 Jun; 32(6):728-36. PubMed ID: 19827120
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma of the head and neck in patients under 40 years of age.
Mendez P; Maves MD; Panje WR
Arch Otolaryngol; 1985 Nov; 111(11):762-4. PubMed ID: 4051867
[TBL] [Abstract][Full Text] [Related]
6. Trends of head and neck cancers in urban and rural India.
Elango JK; Gangadharan P; Sumithra S; Kuriakose MA
Asian Pac J Cancer Prev; 2006; 7(1):108-12. PubMed ID: 16629526
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
Busquets JM; García HA; Trinidad-Pinedo J; Baez A
P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
[TBL] [Abstract][Full Text] [Related]
8. Trends in cancer of the head and neck in the elderly in Denmark, 1980-2012.
Johansen J; Grau Eriksen J;
Acta Oncol; 2016; 55 Suppl 1():13-8. PubMed ID: 26760291
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
11. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
12. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
[TBL] [Abstract][Full Text] [Related]
13. Hypofolatemia as a risk factor for head and neck cancer.
Paludetti G; Almadori G; Bussu F; Galli J; Cadoni G; Maurizi M
Adv Otorhinolaryngol; 2005; 62():12-24. PubMed ID: 15608414
[TBL] [Abstract][Full Text] [Related]
14. Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer.
Iwatsubo T; Ishihara R; Morishima T; Maekawa A; Nakagawa K; Arao M; Ohmori M; Iwagami H; Matsuno K; Inoue S; Nakahira H; Matsuura N; Shichijo S; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Miyashiro I; Higuchi K; Fujii T
BMC Cancer; 2019 Jan; 19(1):3. PubMed ID: 30606157
[TBL] [Abstract][Full Text] [Related]
15. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
Matoscevic K; Graf N; Pezier TF; Huber GF
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
[TBL] [Abstract][Full Text] [Related]
16. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
[TBL] [Abstract][Full Text] [Related]
17. Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population.
Peterson LA; Bellile EL; Wolf GT; Virani S; Shuman AG; Taylor JM; Rozek LS;
Head Neck; 2016 Dec; 38(12):1810-1820. PubMed ID: 27432208
[TBL] [Abstract][Full Text] [Related]
18. Current status of superficial pharyngeal squamous cell carcinoma in Japan.
Rikitake R; Ando M; Saito Y; Yoshimoto S; Yamasoba T; Higashi T
Int J Clin Oncol; 2017 Oct; 22(5):826-833. PubMed ID: 28501947
[TBL] [Abstract][Full Text] [Related]
19. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
Schlieve T; Heidel RE; Carlson ER
J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
[TBL] [Abstract][Full Text] [Related]
20. Oral and pharyngeal cancer in women.
Zavras AI; Shanmugam P; Shetty D; Dolecek TA; Kaste LM
Dent Clin North Am; 2013 Apr; 57(2):339-55. PubMed ID: 23570809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]